Introduction	O

Adipose	B-Tissue
tissue	I-Tissue
,	O
once	O
viewed	O
as	O
simply	O
a	O
storage	O
and	O
release	O
depot	O
for	O
lipids	O
,	O
is	O
now	O
considered	O
an	O
endocrine	B-Tissue
tissue	I-Tissue
[	O
1	O
,	O
2	O
]	O
that	O
secretes	O
various	O
substances	O
(	O
adipokines	O
)	O
,	O
including	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
,	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
,	O
leptin	O
,	O
adiponectin	O
,	O
resistin	O
,	O
visfatin	O
,	O
and	O
omenetin	O
[	O
3	O
,	O
4	O
]	O
.	O

Among	O
these	O
adipokines	O
,	O
much	O
attention	O
has	O
been	O
paid	O
to	O
adiponectin	O
'	O
s	O
relationship	O
with	O
insulin	O
sensitivity	O
and	O
glucose	O
and	O
lipid	O
metabolism	O
in	O
the	O
past	O
10	O
years	O
.	O

In	O
addition	O
,	O
adiponectin	O
is	O
known	O
to	O
exhibit	O
potent	O
anti	O
-	O
inflammatory	O
[	O
5	O
]	O
,	O
atheroprotective	O
[	O
6	O
]	O
,	O
and	O
antidiabetic	O
[	O
7	O
]	O
effects	O
.	O

Recent	O
findings	O
suggest	O
that	O
adiponectin	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
.	O

Levels	O
of	O
adiponectin	O
in	O
synovial	B-Organism_substance
fluid	I-Organism_substance
and	O
sera	B-Organism_substance
were	O
elevated	O
in	O
patients	O
with	O
RA	O
[	O
8	O
,	O
9	O
]	O
.	O

Adiponectin	O
also	O
induces	O
the	O
production	O
of	O
proinflammatory	O
cytokines	O
,	O
IL	O
-	O
6	O
,	O
matrix	O
metalloproteinase	O
(	O
MMP	O
)	O
-	O
1	O
,	O
and	O
IL	O
-	O
8	O
from	O
RA	O
synovial	B-Cell
fibroblasts	I-Cell
in	O
vitro	O
[	O
10	O
,	O
11	O
]	O
.	O

Thus	O
,	O
it	O
was	O
suggested	O
that	O
adiponectin	O
can	O
also	O
exert	O
significant	O
proinflammatory	O
and	O
matrix	O
-	O
degrading	O
effects	O
.	O

However	O
,	O
the	O
role	O
of	O
adiponectin	O
in	O
the	O
pathogenesis	O
of	O
RA	O
is	O
still	O
controversial	O
because	O
of	O
conflicting	O
reports	O
about	O
its	O
function	O
[	O
10	O
,	O
12	O
-	O
15	O
]	O
.	O

In	O
particular	O
,	O
adiponectin	O
seems	O
to	O
play	O
an	O
anti	O
-	O
inflammatory	O
role	O
because	O
it	O
significantly	O
inhibited	O
IL	O
-	O
1beta	O
-	O
stimulated	O
synovial	B-Cell
cell	I-Cell
proliferation	O
in	O
collagen	O
-	O
induced	O
arthritic	O
mice	O
,	O
despite	O
increased	O
IL	O
-	O
6	O
expression	O
[	O
16	O
]	O
.	O

In	O
contrast	O
,	O
high	O
-	O
grade	O
inflammation	O
in	O
RA	O
patients	O
was	O
negatively	O
correlated	O
with	O
circulating	O
adiponectin	O
concentrations	O
[	O
17	O
]	O
.	O

Rather	O
,	O
it	O
was	O
suggested	O
that	O
circulating	O
adiponectin	O
may	O
be	O
involved	O
in	O
cardiovascular	B-Anatomical_system
disease	O
in	O
RA	O
patients	O
.	O

Although	O
this	O
contradiction	O
was	O
partly	O
explained	O
by	O
the	O
induction	O
of	O
tolerance	O
to	O
inflammatory	O
stimuli	O
by	O
adiponectin	O
[	O
18	O
]	O
,	O
the	O
pro	O
-	O
or	O
anti	O
-	O
inflammatory	O
effects	O
of	O
adiponectin	O
on	O
the	O
pathogenesis	O
of	O
RA	O
remain	O
unknown	O
.	O

With	O
regard	O
to	O
adiponectin	O
'	O
s	O
proinflammatory	O
effects	O
,	O
we	O
wondered	O
whether	O
adiponectin	O
might	O
stimulate	O
the	O
production	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
and	O
MMPs	O
as	O
well	O
as	O
proinflammatory	O
mediators	O
like	O
IL	O
-	O
1beta	O
and	O
TNF	O
-	O
alpha	O
do	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
stimulatory	O
effect	O
of	O
adiponectin	O
on	O
the	O
production	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
prostaglandin	O
E2	O
(	O
PGE2	O
)	O
,	O
VEGF	O
,	O
and	O
MMPs	O
.	O

In	O
addition	O
,	O
the	O
correlation	O
between	O
adiponectin	O
and	O
VEGF	O
or	O
MMPs	O
was	O
investigated	O
by	O
measuring	O
the	O
levels	O
of	O
these	O
three	O
proteins	O
in	O
the	O
joint	B-Organism_substance
fluid	I-Organism_substance
of	O
patients	O
with	O
RA	O
or	O
osteoarthritis	O
(	O
OA	O
)	O
.	O

